Inventor
KILBURN JOHN PAUL
DK29 patents
⚠️ This page may combine multiple inventors who share the name “KILBURN JOHN PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
9 patentsUS9593105B2Mar 14, 2017
Cyclic amines
H LUNDBECK AS5 citations83
US9415055B2Aug 16, 2016
Cyclic amines
H LUNDBECK AS4 citations83
US9861639B2Jan 9, 2018
Cyclic amines
H LUNDBECK AS1 citations62
US11358971B2Jun 14, 2022
Prodrugs of modulators of the NMDA receptor
H LUNDBECK AS1 citations60
US9801878B2Oct 31, 2017
Quinoline derivatives as PDE10A enzyme inhibitors
H LUNDBECK AS0 citations51
US9669029B2Jun 6, 2017
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors
H LUNDBECK AS0 citations51
US9649308B2May 16, 2017
Benzamide-containing compounds and their use in the treatment of pain
H LUNDBECK AS1 citations51
US11466027B2Oct 11, 2022
Modulators of the NMDA receptor
H LUNDBECK AS0 citations50
US9592230B2Mar 14, 2017
Substituted imidazoles as PDE10A inhibitors
H LUNDBECK AS0 citations49
LUNDBECK & CO AS H
8 patentsUS9102591B2Aug 11, 2015
Benzamides
LUNDBECK & CO AS H6 citations83
US9108938B2Aug 18, 2015
Cyclic amines
LUNDBECK & CO AS H7 citations82
US9018217B2Apr 28, 2015
Phenylimidazole derivatives as PDE10A enzyme inhibitors
LUNDBECK & CO AS H1 citations60
US9062060B2Jun 23, 2015
Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors
LUNDBECK & CO AS H0 citations52
US8796304B2Aug 5, 2014
Tricyclic imidazole compounds as PDE10 inhibitors
LUNDBECK & CO AS H0 citations52
US9216986B1Dec 22, 2015
Quinoline derivatives as PDE10A enzyme inhibitors
LUNDBECK & CO AS H0 citations51
US8927738B2Jan 6, 2015
2-arylimidazole derivatives as PDE10A enzyme inhibitors
LUNDBECK & CO AS H0 citations49
US8785653B2Jul 22, 2014
(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivatives
LUNDBECK & CO AS H0 citations49